US Biotechnology "*Invite* HypoPTH Doc Dinner Jun 12 at ENDO 2026 in Chi..."

研报英文原文证据摘录

US Biotechnology "*Invite* HypoPTH Doc Dinner Jun 12 at ENDO 2026 in Chi..."

Global Research

11 June 2026ab

US Biotechnology Equities

Americas*Invite* HypoPTH Doc Dinner Jun 12 at ENDO

2026 in Chicago – MBX, ASND, BBIO, SEPN Biotechnology

Michael Yee

Analyst

michael.yee@ubs.com

+1-305-536 9101

We are pleased to invite you to join a physician discussion with Dr. Daniel Katselnik, a Dina Elmonshed

practicing endocrinologist who treats patients with hypoparathyroidism in his day to day Analyst

clinical practice. This discussion will be focused on how physicians manage dina.elmonshed@ubs.com

hypoparathyroidism patients in practice today. Dr. Katselnik will share practical insights +1-212-649 8276

from his own experience, including topics below. Kyle Yang, CFA

Associate Analyst

Relevant tickers: ASND, BBIO, MBX, SEPN, AZN kyle.yang@ubs.com

+1-212-713 1458

We hope you will be able to join us for this candid and informative discussion. Please Matthew Hagood

Associate Analystreach out to us or your UBS sales representative if you are interested in attending.

matthew.hagood@ubs.com

+1-212-713 1107

Event Details

Madeleine Lee

Date: June 12th, 2026 Associate Analyst

madeleine.lee@ubs.com

Time: 6:30 – 8:00 PM CT +1-212-713 1476

Location: Chicago Roy Zawadzki, PhD

UBS Hosts: roy.zawadzki@ubs.com

+1-212-713 1139

Mike Yee, Global Head of Biotechnology Research

Anson Dang, PhD

Kyle Yang, Biotechnology Research Associate Analyst Associate Analyst

anson.dang@ubs.com

Discussion Topics: +1-212-649 7544

How hypoparathyroidism patients present and are managed in routine clinical care

Use of calcium and vitamin D, and how therapy is adjusted over time

How treatment decisions are made in real world settings

Real world experience with Yorvipath, including patient selection and

management